Product Introduction
IMA
Key words:
Classification:
- 产品描述
-
- Commodity name: IMA
- Commodity ID: 1344952583826591744
This reagent is used to quantitatively determine the concentration of ischemic modified albumin (IMA) in human serum in vitro.
Ischemic modified albumin (IMA) refers to the albumin whose N-terminal amino acid is modified (the binding site is occupied by copper ions or is acetylated or deleted) when tissue ischemia and reperfusion occurs. The characteristic is that the ability to bond with transition metals (nickel copper cobalt) is reduced. IMA is an early indicator of cell necrosis after myocardial ischemia, and its elevated level is also related to the severity of myocardial ischemia. Clinically, IMA is mainly used for early diagnosis of acute myocardial ischemia, and early diagnosis and risk stratification of acute coronary syndrome (ACS) (for reference only).
More products
Contact Phone

Customer service : 400-650-8635

Contact Number : +86-10-80485160 / 80485161

Sales call : +86-10-64421344 / 64410842

Address:First and third floor of No.7 building, No.28 YuHua road, Airport economic core area,Shunyi District, Beijing, P.R.China

E-mail : service@homabio.com

Follow HOMA
Copyright: Beijing Homa biological engineering co., LTD Powered by 300.cn Label